What is it?
Overview
3Yohimbine is an indole alkaloid from yohimbe bark and a pharmacologically active alpha-2 adrenergic antagonist. It is better framed as a high-caution adrenergic compound than as a broad nootropic: the human evidence is concentrated in erectile-function and pharmacology studies, while cognitive-performance claims remain weak.
Names, aliases and forms
Mechanisms of action
Mechanism snapshot
8Yohimbine blocks alpha-2 adrenergic receptors, including presynaptic autoreceptors that normally restrain norepinephrine release. That mechanism can increase noradrenergic tone, which helps explain both activating effects and adverse effects such as anxiety, palpitations, and blood-pressure sensitivity.
Potential effects and evidence map
Yohimbine has human pharmacology data and modest clinical evidence in erectile-function studies of purified yohimbine HCl, but the evidence does not establish broad cognitive benefit. Small performance/body-composition studies are limited, and safety/product-quality literature supports a high-caution profile for supplement use.
may feel activating through adrenergic stimulation, but this is not the same as demonstrated cognitive-performance benefit
has modest human evidence in erectile-function studies of purified yohimbine HCl, with limited relevance to OTC yohimbe bark supplements
has limited human performance evidence; a small soccer-player trial did not improve measured exercise-performance outcomes
Typical dosages and timing
Clinical references for purified yohimbine HCl commonly discuss low milligram doses, but supplement labels can be inaccurate and yohimbe bark products are not interchangeable with standardized yohimbine HCl. Treat this as study context, not a recommendation.
Onset, duration and tolerance
Safety, side effects and risk profile
Tachycardia, hypertension, chest symptoms, and more severe outcomes have been reported with yohimbine-containing products.
Anxiety, agitation, tremor, palpitations, and insomnia-like stimulation are plausible and clinically documented concerns.
Stimulants, MAOIs, some antidepressants, ADHD medications, and blood-pressure-active drugs raise interaction concerns.
Pregnancy and lactation safety is not established, and the adrenergic risk profile makes conservative avoidance appropriate.
Regulatory treatment differs by product type and jurisdiction; OTC products cannot be marketed as ED treatments in the U.S. without FDA approval.
Yohimbe bark supplements vary in composition, and clinical yohimbine HCl evidence should not be generalized to every supplement product.
Interactions and cautions
Potentially risky combinations include stimulant-heavy products, caffeine or ephedra-style stimulants, ADHD stimulants, MAOIs, certain antidepressants, and blood-pressure-active medications. FDA safety notices also flag greater risk in people taking stimulants, ADHD medications, MAOIs, or some antidepressants.
Legal and regulatory status
In the United States, dietary supplements are not approved by FDA before sale, and NCCIH notes that an over-the-counter yohimbine product cannot legally be marketed as an erectile-dysfunction treatment without FDA approval. European safety assessments found insufficient characterization of yohimbe bark preparations to establish safe food-supplement use.
How it compares
Most clinical evidence concerns purified yohimbine HCl, while yohimbe bark extracts can vary in alkaloid content and may contain related alkaloids. Product analyses found large differences between labeled and measured yohimbine content.
Practical buying and quality notes
- Avoid treating generic yohimbe bark blends as equivalent to quantified yohimbine HCl. The safest quality screen is a product that clearly states yohimbine amount, avoids stimulant stacking, and provides independent testing for identity and dose accuracy.5
FAQ
Is yohimbine a nootropic?
3Not in the usual evidence-based sense. It has adrenergic stimulant-like pharmacology, but human evidence does not establish reliable focus, memory, or learning benefits.
Is yohimbe bark the same as yohimbine HCl?
5No. Yohimbine HCl is the purified salt form used in much of the clinical literature. Yohimbe bark supplements can vary substantially in alkaloid content and labeling accuracy.
Who should avoid yohimbine?
1People with cardiovascular disease, uncontrolled hypertension, anxiety or panic disorders, stimulant sensitivity, pregnancy or lactation, or use of stimulants, ADHD medications, MAOIs, certain antidepressants, or blood-pressure-active medications should avoid yohimbine unless a qualified clinician specifically advises otherwise.
References
- National Center for Complementary and Integrative Health. Yohimbe: Usefulness and Safety. Last updated May 2025.
- National Institute of Diabetes and Digestive and Kidney Diseases. Yohimbine. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury.
- Tam SW, Worcel M, Wyllie M. Yohimbine: a clinical review. Pharmacology & Therapeutics. 2001;91(3):215-243.
- Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. Journal of Urology. 1998;159(2):433-436.
- Cohen PA, Wang YH, Maller G, DeSouza R, Khan IA. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Testing and Analysis. 2016;8(3-4):357-369.
- Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases. Annals of Pharmacotherapy. 2010;44(6):1022-1029.
- Charney DS, Heninger GR, Breier A. Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Archives of General Psychiatry. 1984;41(8):751-763.
- Hedner T, Edgar B, Edvinsson L, Hedner J, Persson B. Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers. European Journal of Clinical Pharmacology. 1992;43(6):651-656.
- Guthrie SK, Hariharan M, Grunhaus LJ. Yohimbine bioavailability in humans. European Journal of Clinical Pharmacology. 1990;39(4):409-411.
- Ostojic SM. Yohimbine: the effects on body composition and exercise performance in soccer players. Research in Sports Medicine. 2006;14(4):289-299.
- Cimolai N, Cimolai T. Yohimbine use for physical enhancement and its potential toxicity. Journal of Dietary Supplements. 2011;8(4):346-354.
- EFSA Panel on Food Additives and Nutrient Sources Added to Food. Scientific Opinion on the evaluation of the safety in use of Yohimbe (Pausinystalia yohimbe). EFSA Journal. 2013;11(7):3302.
- U.S. Food and Drug Administration. Branch Manager for Men may be harmful due to hidden drug ingredient. Medication Health Fraud Notification. Content current as of June 10, 2026.